Pant V - Search Results

1

Contrasting effects of an Mdm2 functional polymorphism on tumor phenotypes.

Ortiz GJ, Li Y, Post SM, Pant V, Xiong S, Larsson CA, El-Naggar AK, Johnson DG, Lozano G. Ortiz GJ, et al. Among authors: pant v. Oncogene. 2018 Jan 18;37(3):332-340. doi: 10.1038/onc.2017.344. Epub 2017 Sep 18. Oncogene. 2018. PMID: 28925402 Free PMC article.

2

Spontaneous tumorigenesis in mice overexpressing the p53-negative regulator Mdm4.

Xiong S, Pant V, Suh YA, Van Pelt CS, Wang Y, Valentin-Vega YA, Post SM, Lozano G. Xiong S, et al. Among authors: pant v. Cancer Res. 2010 Sep 15;70(18):7148-54. doi: 10.1158/0008-5472.CAN-10-1457. Epub 2010 Aug 24. Cancer Res. 2010. PMID: 20736370 Free PMC article.

3

A high-frequency regulatory polymorphism in the p53 pathway accelerates tumor development.

Post SM, Quintás-Cardama A, Pant V, Iwakuma T, Hamir A, Jackson JG, Maccio DR, Bond GL, Johnson DG, Levine AJ, Lozano G. Post SM, et al. Among authors: pant v. Cancer Cell. 2010 Sep 14;18(3):220-30. doi: 10.1016/j.ccr.2010.07.010. Cancer Cell. 2010. PMID: 20832750 Free PMC article.

4

Prognostic impact of the MDM2SNP309 allele in leukemia and lymphoma.

Post SM, Pant V, Abbas H, Quintás-Cardama A. Post SM, et al. Among authors: pant v. Oncotarget. 2010 Jul;1(3):168-174. doi: 10.18632/oncotarget.123. Oncotarget. 2010. PMID: 21301048 Free PMC article. Review.

5

Heterodimerization of Mdm2 and Mdm4 is critical for regulating p53 activity during embryogenesis but dispensable for p53 and Mdm2 stability.

Pant V, Xiong S, Iwakuma T, Quintás-Cardama A, Lozano G. Pant V, et al. Proc Natl Acad Sci U S A. 2011 Jul 19;108(29):11995-2000. doi: 10.1073/pnas.1102241108. Epub 2011 Jul 5. Proc Natl Acad Sci U S A. 2011. PMID: 21730132 Free PMC article.

6

The ups and downs of p53 regulation in hematopoietic stem cells.

Abbas HA, Pant V, Lozano G. Abbas HA, et al. Among authors: pant v. Cell Cycle. 2011 Oct 1;10(19):3257-62. doi: 10.4161/cc.10.19.17721. Epub 2011 Oct 1. Cell Cycle. 2011. PMID: 21957490 Free PMC article.

7

p53-mediated senescence impairs the apoptotic response to chemotherapy and clinical outcome in breast cancer.

Jackson JG, Pant V, Li Q, Chang LL, Quintás-Cardama A, Garza D, Tavana O, Yang P, Manshouri T, Li Y, El-Naggar AK, Lozano G. Jackson JG, et al. Among authors: pant v. Cancer Cell. 2012 Jun 12;21(6):793-806. doi: 10.1016/j.ccr.2012.04.027. Cancer Cell. 2012. PMID: 22698404 Free PMC article.

8

The p53 pathway in hematopoiesis: lessons from mouse models, implications for humans.

Pant V, Quintás-Cardama A, Lozano G. Pant V, et al. Blood. 2012 Dec 20;120(26):5118-27. doi: 10.1182/blood-2012-05-356014. Epub 2012 Sep 27. Blood. 2012. PMID: 23018641 Free PMC article. Review.

9

The p53-Mdm2 feedback loop protects against DNA damage by inhibiting p53 activity but is dispensable for p53 stability, development, and longevity.

Pant V, Xiong S, Jackson JG, Post SM, Abbas HA, Quintás-Cardama A, Hamir AN, Lozano G. Pant V, et al. Genes Dev. 2013 Sep 1;27(17):1857-67. doi: 10.1101/gad.227249.113. Epub 2013 Aug 23. Genes Dev. 2013. PMID: 23973961 Free PMC article.

10

Dissecting the p53-Mdm2 feedback loop in vivo: uncoupling the role in p53 stability and activity.

Pant V, Lozano G. Pant V, et al. Oncotarget. 2014 Mar 15;5(5):1149-56. doi: 10.18632/oncotarget.1797. Oncotarget. 2014. PMID: 24658419 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

122 results

Search Page

Filters